Evaluation of Factors Predicting the Effectiveness of Regorafenib in the Treatment of Metastatic Colorectal Cancer

Ítems similars

• Factors predicting pathological complete response to neoadjuvant chemotherapy in patients diagnosed with non-metastatic muscle invasive urothelial bladder cancer
  per: Zuhat Urakçı, et al.
  Publicat: (2023-10-01)
• The importance of serum and pleural fluid level of vascular endothelial growth factor (VEGF) and VEGF fluid/serum ratio in the differential diagnosis of malignant mesothelioma-related pleural effusion
  per: Yakup Düzköprü, et al.
  Publicat: (2017-09-01)
• Clinical Implication of Anti-Angiogenic Effect of Regorafenib in Metastatic Colorectal Cancer.
  per: Yoojoo Lim, et al.
  Publicat: (2015-01-01)
• Cost-Effectiveness Analysis of Regorafenib versus Other Third-Line Treatments for Metastatic Colorectal Cancer
  per: Zhong J, et al.
  Publicat: (2024-06-01)
• Research progress of regorafenib in the treatment of colorectal cancer
  per: CHEN Yixuan, et al.
  Publicat: (2024-09-01)